跳至主要内容
临床试验/NCT05910047
NCT05910047已完成不适用

The Effects of Six-week Hydrogen Plus Pyrroloquinoline Quinone (PQQ) Intake on Mitochondrial Biomarkers, Brain Metabolism and Cognition in the Elderly With Mild Cognitive Impairment

University of Novi Sad, Faculty of Sport and Physical Education1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2023年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
34
试验地点
1
主要终点
Fibroblast growth factor 21

研究概览

简要总结

The goal of this randomized controlled double-blind parallel-group interventional trial is to evaluate the effects of dietary supplementation with molecular hydrogen and pyrroloquinoline quinone in elderly. The main questions it aims to answer are: (1) whether the supplementation affects biomarkers of mitochondrial function in serum, and (2) whether the supplementation affects cognition and brain metabolism. The participants will be subjected to take the dietary supplement during 6 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age > 65 years
  • •MMSE scores ranged from 23-27
  • •Informed consent signed

排除标准

  • •Take part in exercise on a regular basis
  • •Severe chronic disease and acute injuries
  • •History of dietary supplement use during the past 4weeks
  • •No consent to randomization
  • •Participation in other studies

研究组 & 干预措施

Supplement

Experimental

One tablet of supplement before breakfast and dinner

干预措施: Supplement (Dietary Supplement)

Placebo

Placebo Comparator

One tablet of inert compound before breakfast and dinner

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Fibroblast growth factor 21

时间窗: Change from baseline serum fibroblast growth factor 21 at 6 weeks

Level of fibroblast growth factor 21 in serum

次要结局

  • Peroxisome proliferator-activated receptor gamma coactivator 1-alpha(Change from baseline serum peroxisome proliferator-activated receptor gamma coactivator 1-alpha at 6 weeks)
  • Brain creatine(Change from baseline brain creatine at 6 weeks)
  • Brain-derived neurotrophic factor(Change from baseline serum brain-derived neurotrophic factor at 6 weeks)
  • Irisin(Change from baseline serum irisin at 6 weeks)
  • General cognition(Change from baseline MMSE score at 6 weeks)
  • Brain oxygenation(Change from baseline brain oxygenation at 6 weeks)

研究者

发起方
University of Novi Sad, Faculty of Sport and Physical Education
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sergej Ostojic

Professor

University of Novi Sad, Faculty of Sport and Physical Education

研究点 (1)

Loading locations...

相似试验